Back to search

Article

Two novel mgCas12a proteins from the human gut metagenome exhibit reduced collateral DNase activity

2022-07-06

Abstract excerpt

CRISPR/Cas9 and CRISPR/Cas12a are characterized by a single-component effector protein. Despite unique features like DNA cleavage with 5′ staggered ends and a single crRNA, Cas12a has not been adopted in therapeutics to the same extent as Cas9. To address the pressing therapeutic needs for effective CRISPR/Cas12 systems, we selected two candidates, designated mgCas12a-1 and mgCas12a-2, from an analysis of the huma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
40108715-c96c-5aea-a174-14afe0d893a5
DOI
10.21203/rs.3.rs-1720912/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Two novel mgCas12a proteins from the human gut metagenome exhibit reduced collateral DNase activityDOI 10.21203/rs.3.rs-1720912/v1
Select a neighboring publication to make it the new centre.